Skip to content

Drug interactions

Amlodipine-olmesartan + Ceftobiprole medocaril

Severity: Moderate

Amlodipine-olmesartan and Ceftobiprole medocaril: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ceftobiprole inhibits OATP1B1 and OATP1B3, and olmesartan is a substrate of these hepatic uptake transporters. Olmesartan exposure may rise modestly, with a possible increase in hypotension or other adverse effects.

What this interaction means in plain words

Amlodipine-olmesartan and Ceftobiprole medocaril can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Ceftobiprole inhibits OATP1B1/1B3 hepatic uptake of olmesartan.

What to do

Monitor blood pressure and renal function during ceftobiprole therapy. Reduce the olmesartan dose if hypotension occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amlodipine-olmesartan and Ceftobiprole medocaril, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Amlodipine-olmesartan with Ceftobiprole medocaril?

MediHelp rates the interaction as moderate. Amlodipine-olmesartan and Ceftobiprole medocaril can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ceftobiprole inhibits OATP1B1 and OATP1B3, and olmesartan is a substrate of these hepatic uptake transporters. Olmesartan exposure may rise modestly, with a possible increase in hypotension or other adverse effects.

How serious is the interaction between Amlodipine-olmesartan and Ceftobiprole medocaril?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and renal function during ceftobiprole therapy. Reduce the olmesartan dose if hypotension occurs.

What other medicines interact with Amlodipine-olmesartan?

MediHelp also lists interactions of Amlodipine-olmesartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Amlodipine-olmesartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in